Cognition Therapeutics in the News
Cognition Therapeutics aims to stop memory loss with breakthrough Alzheimer’s drug
December 20, 2016
Cognition Therapeutics, a Pittsburgh company that specializes in treating neurocognitive disorders, has taken the next step to developing an innovative new drug for treating Alzheimer’s disease.
Focusing on synaptic protection in Alzheimer’s
October 26, 2016
Cognition Therapeutics, Inc. has a first-in-class, clinical-stage, highly brain-penetrant and orally bioavailable small molecule designed to halt the initiation and progression of Alzheimer’s disease.
New drug could slow or halt Alzheimer’s, says leader of clinical trials
October 16, 2016
"The worst thing about dementia is that you progressively lose the person that you love," says Anne Tudor, and she knows it first hand.
Her partner, Edie Mayhew, 65, was diagnosed six years ago with early onset Alzheimer's disease.